Amygdalin (Laetrile) and HIV: Absence of Antiretroviral Activity and Documented Cyanide Toxicity
1. Introduction: A Persistent Myth in the Shadow of the AIDS Crisis Among the many unproven substances promoted during the…
1. Introduction: A Persistent Myth in the Shadow of the AIDS Crisis Among the many unproven substances promoted during the…
1. Introduction: The Rationale for Modulating Immunity in HIV Antiretroviral therapy (ART) controls HIV by blocking viral replication, but it…
1. Introduction: Why the Gut Matters in HIV HIV is often described as a disease of the immune system, but…
1. Introduction: Prevention Vaccines Versus Post-Infection Vaccines Vaccines against infectious diseases are usually understood as preventive: they are given before…
1. Introduction: A Monoclonal Antibody Against CCR5 Leronlimab, also known by its development name PRO 140, is a humanized IgG4…
1. Introduction: An Entry Inhibitor That Targets the Host Maraviroc (marketed as Selzentry in the United States and Celsentri in…
1. Introduction: Definition and Rationale Post-exposure prophylaxis (PEP) for HIV is the short-term use of antiretroviral drugs to prevent infection…
1. Introduction: A New Class of Antiretroviral For four decades, the pharmacological treatment and prevention of HIV-1 has been dominated…
1. Introduction: Injectable Pre-Exposure Prophylaxis Cabotegravir is an integrase strand transfer inhibitor (INSTI) that was reformulated as a long-acting injectable…
1. Introduction: A Topical Option for Women’s HIV Prevention HIV prevention has historically relied heavily on tools that are either…